Latest Cord blood Stories
Collaboration will evaluate menstrual stem cells for future potential diabetes therapy Oldsmar, Fla (PRWEB) February 07, 2012 Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) and Stanford University announced signing a material transfer agreement to test the efficacy of mesenchymal-like stem cells derived from menstrual blood (MenSCs) in a model of pancreatic islet transplantation for type 1 diabetes treatment. Specifically, the menstrual blood stem cells provided by...
RANCHO CORDOVA, Calif., Feb. 1, 2012 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, today provided updates on two clinical evaluations involving its Res-Q® 60 BMC (Res-Q) system, a point-of-care platform designed for the preparation of cell concentrates from bone marrow. Speaking at the Seventh International Conference on Cell Therapy for Cardiovascular Disease, Vijay Kumar,...
Scientists with the new Children’s Research Institute at UT Southwestern Medical Center have identified the environment in which blood-forming stem cells survive and thrive within the body, an important step toward increasing the safety and effectiveness of bone-marrow transplantation. Institute investigators led by Dr. Sean Morrison asked which cells are responsible for the microenvironment that nurtures haematopoietic stem cells, which produce billions of new blood cells every day. The...
LAS VEGAS, Jan. 25, 2012 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today reports that umbilical cord blood stem cells have been successfully used to treat individuals with type 1 diabetes, highlighting the importance of storing stem cells at birth....
RANCHO CORDOVA, Calif., Jan. 23, 2012 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today, it had received an initial order for its BioArchive(®) System from a new public cord blood bank that will begin operations in Canada in early 2013. Canadian Blood Services, a national charitable organization that manages the supply of blood and blood products in all Canadian provinces...
NEWTON, Mass., Jan. 18, 2012 /PRNewswire/ -- New England Cord Blood Bank is pleased to announce today that it is expanding its services in cord blood stem cell banking to the state of New Jersey. New England Cord Blood Bank (NECBB) and its parent company, The New England Cryogenic Center have been pioneering forces in the cryogenic preservation of cells for over 30 years. At its International Headquarters, located outside of Boston, Massachusetts, NECBB processes and stores...
HOUSTON, Jan. 12, 2012 /PRNewswire/ -- Children's Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss. To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss (Logo:...
With the potential of replacing defective or damaged cells resulting from disorders and injuries, stem cells are of great interest, leading to a variety of new regenerative therapies. New research report “Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development” prepared by Kalorama Information has been recently published by Market Publishers Ltd. London, UK (PRWEB) January 11, 2012 With the potential of replacing defective or damaged cells resulting...
LAS VEGAS and SAO PAULO, Brazil, Jan. 9, 2012 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. (BioCells, Inc.) is opening a new franchise headquartered in Campinas, Brazil, a city of more than one million in the state of...
RANCHO CORDOVA, Calif., Jan. 5, 2012 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today it will be participating in the OneMedForumSF 2012 Conference on Tuesday, January 10(th). The presentation by Matthew T. Plavan, Chief Financial Officer and Executive Vice President of Business Development, will begin at 11:15 a.m., Pacific Standard Time (2:15 p.m., Eastern Standard Time)....
